Now that our #ISSAD2026 delegates are back home and settled into their routines, we want to say a huge THANK YOU for making the 4th International Symposium on Streptoccocus agalactiae disease so impactful. #GBS #ISSAD2026

Day 2’s sessions shifted the focus to the GBS vaccine pipeline and the complex policy frameworks required to ensure global access. The energy among our 37-country delegation remained high as we moved into the final day of the symposium!🔬 #ISSAD2026 #PublicHealth

"Collaboration is the bridge between policy & impact." We were honoured to host Ms MARY MUTHONI, CBS, HSC., Principal Secretary in the State Department for Public Health (@MOH_Kenya), at our gala dinner. @KEMRI_Kenya

Our Expert Panel: 👤 Michelle Groome | Global South Perspectives 👤 Martha Mandale | Safety Surveillance 👤 Ignacio Esteban | Financing the Future 👤 Violet Naanyu | Prioritizing Equity

Plenary 5 at #ISSAD2026 has taken us From Evidence to Action, moving beyond the lab to talk about how we actually reach the mothers & babies who need these vaccines most. Because a vaccine only works if it's accessible, sustainable, & safe for everyone. #ISSAD #GlobalHealth

The science of GBS vaccines is advancing rapidly, but how do we implement them? In Plenary 4, we look at the evidence and economics behind the rollout. #ISSAD2026 #GBS #GlobalHealth

🔬 Per Fischer with progress toward the pivotal trial for the AlpN Vaccine. 🔬 Shabir Madhi on interim results from the Phase 1/2 study of IVT GBS-06 in healthy adult non-pregnant women. 🔬 Roberto Adamo on a Polysaccharide-Based GBS Vaccine tailored for global health.

Plenary 3 at #ISSAD2026 has the architects of the next generation of maternal immunisation. From the lab bench to phase trials, this is where the future of neonatal protection is being written. #ISSAD2026 #VaccineDevelopment #GBS #GlobalHealth

🔬 Victor Akelo from the CHAMPS network on stillbirths attributed to GBS. 🔬 Anna Seale on scientific gaps in maternal GBS sepsis and GBS-associated preterm birth. 🔬 Susan Meiring on surveillance challenges & findings of invasive GBS in non-pregnant adults in South Africa.

The session concluded with a critical Panel Discussion: How to Move Forward?, moderated by the esteemed Joy Lawn. Evidence is only as strong as our ability to measure it. Join us as we refine our lens on global GBS surveillance.